Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

May 3, 2018 | REGULATORY

Immunovia—report from AGM

Read press release
April 27, 2018 | REGULATORY

Immunovia Interim report, January-March 2018

Read press release
April 25, 2018

Invitation to presentation of Immunovia´s interim report January-March 2018 on April 27, 2018

Read press release
April 25, 2018

Invitation to presentation of Immunovia´s interim report January-March 2018 on April 27, 2018

Read press release
April 12, 2018

NYU School of Medicine joins PanFAM-1 prospective study for the early detection of pancreatic cancer in familiar risk groups

Read press release
April 3, 2018 | REGULATORY

Kallelse till Årsstämma i Immunovia AB

Read press release
March 26, 2018

Immunovia published prospectus in connection with the change of listing venue to Nasdaq Stockholm

Read press release
March 26, 2018

Immunovia has been approved for listing on Nasdaq Stockholm

Read press release
March 23, 2018

Immunovia launches new website today

Read press release
March 12, 2018 | REGULATORY

Immunovia announces financial targets

Read press release
February 16, 2018

Spanish center Santiago de Compostela joins the largest ever prospective study into familial risk of developing pancreatic cancer

Read press release
February 15, 2018 | REGULATORY

Immunovia Full Year report, January-December 2017

Read press release
1 18 19 20 21 22 27